檔案名稱:rp-1/rHuGH20K.html

重組蛋白目錄

本類目錄


Recombinant Human Pituitary Growth Hormone-20K

Certificate of Analysis and Data Sheet

Source:
E.Coli

Catalog No.
CYT-259

Description :

Recombinant Human GH-20K produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 177 amino acids and having a molecular mass of 20322 Dalton. GH-20K is purified by proprietary chromatographic techniques.

Physical Appearance:

Sterile Filtered White lyophilized (freeze-dried) powder.

Formulation:

The protein was lyophilized from a concentrated (1mg/ml) solution with 0.0045mM NaHCO3 previously adjusted pH 10.

Solubility:

It is recommended to reconstitute and dilute the lyophilized GH-20K in 0.4% NaHCO3 adjusted to pH 10 , which can then be further diluted to other aqueous solutions.
It is recommended when diluting to below 10 ug/ml that the dilution solution will contain carrier protein (BSA or other) to avoid non-specific absorption of the hGH to plastic tubes.

Stability:

Lyophilized GH-20K although stable at room temperature for 3 weeks, should be stored desiccated below -18 C. Upon reconstitution GH-20K should be stored at 4 C between 2-7 days and for future use below -18 C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please avoid freeze-thaw cycles.

Purity:

Greater than 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Anion-exchange FPLC. (c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained.

Amino-Acid Sequence :

The sequence of the first five N-terminal amino acids was determined and was found to be Met-Ala-Thr-Gly-Ser.

Dimers and aggregates:

Less than 1% as determined by silver-stained SDS-PAGE gel analysis.

Biological Activity:

ProSpec's rHuGH-20K is fully biologically active when compared to World Health Organization (WHO) reference standard.

Endotoxin:

Less than 0.1 ng/ug (IEU/ug) of GH-20K.

Protein content:

Protein quantitation was carried out by two independent methods: 1. UV spectroscopy at 280 nm using the absorbency value of 0.73 as the extinction coefficient for a 0.1% (1mg/ml) solution. This value is calculated by the PC GENE computer analysis program of protein sequences (IntelliGenetics). 2. Analysis by RP-HPLC, using a calibrated solution of GH-20K as a Reference Standard.

Usage:

Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.


Gene:

Name:GH1

Protein synonyms/aliases:

Somatotropin precursor (Growth hormone)
    (GH)
    (GH-N)
    (Pituitary growthhormone)
    (Growth hormone 1).

Protein Family:

Belongs to the somatotropin/prolactin family.

Protein Domains:


Domains:
IPR001400   Somatotropin hormone

Related proteins:

Recombinant Human Prolactin
Recombinant Ovine Prolactin
Recombinant Human Placental-Corr Growth Hormone-22K
Recombinant Rat Growth Hormone
Recombinant Ovine Growth Hormone
Recombinant bream Growth Hormone

Protein links:

Recombinant Human Pituitary Growth Hormone-20K protein domain

Recombinant Human Pituitary Growth Hormone-20K protein family


Precursor- Protein structure and amino acid sequence:


Latest Publications:

1. Serum levels of 20 kilodalton human growth hormone (20K-hGH) in patients with acromegaly before and after treatment with octreotide and transsphenoidal surgery.
Endocr J 2004 Jun;51(3):343-8
2. Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical trial of 20K-hGH.
J Clin Endocrinol Metab 2004 Apr;89(4):1562-71
3. Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.
Growth Horm IGF Res 2001 Apr;11(2):110-6
4. Effects of 22K or 20K human growth hormone on lipolysis, leptin production in adipocytes in the presence and absence of human growth hormone binding protein.
Horm Res 2000;54(4):203-7
5. Twenty-kilodalton human growth hormone (20K hGH) secretion from growth hormone-secreting pituitary adenoma cells in vitro.
Endocr J 2000 Oct;47(5):563-8
6. Effects of octreotide infusion, surgery and estrogen on suppression of height increase and 20K growth hormone ratio in a girl with gigantism due to a growth hormone-secreting macroadenoma.
Horm Res 2000;53(3):157-60

採購找生工,預算最輕鬆。

回頁首↑ | 回首頁←


中華民國95年06月06日更新